Biolife Solutions (BLFS) Capital Expenditures (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Capital Expenditures data on file, last reported at $167000.0 in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $167000.0, down 4.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.5 million (up 180.51% YoY), and the FY2025 annual result was $9.5 million, up 193.71% from the prior year.
• Capital Expenditures eased to $167000.0 in Q1 2026 per BLFS's latest filing, from $9.0 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $9.0 million in Q4 2025 and troughed at -$5.5 million in Q4 2022.
• A 5-year average of $1.2 million and a median of $981000.0 in 2023 frame the typical range for Capital Expenditures.
• On a YoY basis, Capital Expenditures climbed as much as 1084.78% in 2025 and fell as far as 167.87% in 2025.
• A 5-year view of Capital Expenditures shows it stood at -$5.5 million in 2022, then jumped by 117.97% to $981000.0 in 2023, then decreased by 22.32% to $762000.0 in 2024, then surged by 1084.78% to $9.0 million in 2025, then slumped by 98.15% to $167000.0 in 2026.
• Business Quant data shows BLFS's Capital Expenditures at $167000.0 in Q1 2026, $9.0 million in Q4 2025, and -$1.5 million in Q3 2025.